Literature DB >> 17694278

Physiological stress induces the metastasis marker AGR2 in breast cancer cells.

Daniel R Zweitzig1, Denis A Smirnov, Mark C Connelly, Leon W M M Terstappen, S Mark O'Hara, Elizabeth Moran.   

Abstract

As an approach to understanding the factors that activate expression of tumor progression genes, the role of physiological stress in the activation of a panel of tumor cell markers was investigated. These studies identify the developmental gene product, anterior gradient 2 (AGR2) as a cancer cell marker specifically up-regulated in response to depletion of serum and oxygen. AGR2 has been identified as a tumor marker in primary and secondary cancer lesions, and as a marker for detection of circulating tumor cells (CTCs). Elevated levels of AGR2 are known to increase the metastatic potential of cancer cells, but conditions leading to increased expression of AGR2 are not well understood. The present results identify novel physiological parameters likely to contribute to AGR2 induction in situ.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17694278     DOI: 10.1007/s11010-007-9562-y

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  33 in total

1.  The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage.

Authors:  Elizabeth Pohler; Ashley L Craig; James Cotton; Laura Lawrie; John F Dillon; Pete Ross; Neil Kernohan; Ted R Hupp
Journal:  Mol Cell Proteomics       Date:  2004-02-15       Impact factor: 5.911

2.  Diversity of the protein disulfide isomerase family: identification of breast tumor induced Hag2 and Hag3 as novel members of the protein family.

Authors:  Staffan Persson; Magnus Rosenquist; Barbara Knoblach; Roya Khosravi-Far; Marianne Sommarin; Marek Michalak
Journal:  Mol Phylogenet Evol       Date:  2005-09       Impact factor: 4.286

3.  Nucleus pulposus cells upregulate PI3K/Akt and MEK/ERK signaling pathways under hypoxic conditions and resist apoptosis induced by serum withdrawal.

Authors:  Makarand V Risbud; Jolanta Fertala; Edward J Vresilovic; Todd J Albert; Irving M Shapiro
Journal:  Spine (Phila Pa 1976)       Date:  2005-04-15       Impact factor: 3.468

4.  AGR2, an androgen-inducible secretory protein overexpressed in prostate cancer.

Authors:  Jin-San Zhang; Aiyu Gong; John C Cheville; David I Smith; Charles Y F Young
Journal:  Genes Chromosomes Cancer       Date:  2005-07       Impact factor: 5.006

5.  Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas.

Authors:  Dong Liu; Philip S Rudland; D Ross Sibson; Angela Platt-Higgins; Roger Barraclough
Journal:  Cancer Res       Date:  2005-05-01       Impact factor: 12.701

6.  Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy.

Authors:  K Izuishi; K Kato; T Ogura; T Kinoshita; H Esumi
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

7.  Comparison of proteomic and genomic analyses of the human breast cancer cell line T47D and the antiestrogen-resistant derivative T47D-r.

Authors:  Martina Huber; Inke Bahr; Jörn R Krätzschmar; Andreas Becker; Eva-Christina Müller; Peter Donner; Hans-Dieter Pohlenz; Martin R Schneider; Anette Sommer
Journal:  Mol Cell Proteomics       Date:  2003-10-13       Impact factor: 5.911

8.  hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines.

Authors:  D A Thompson; R J Weigel
Journal:  Biochem Biophys Res Commun       Date:  1998-10-09       Impact factor: 3.575

9.  Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway.

Authors:  Shideng Bao; Gaoliang Ouyang; Xuefang Bai; Zhi Huang; Chaoyu Ma; Ming Liu; Rong Shao; Ryan M Anderson; Jeremy N Rich; Xiao-Fan Wang
Journal:  Cancer Cell       Date:  2004-04       Impact factor: 31.743

Review 10.  Oncogenes and tumor angiogenesis: the question of vascular "supply" and vascular "demand".

Authors:  Janusz Rak; Joanne L Yu
Journal:  Semin Cancer Biol       Date:  2004-04       Impact factor: 15.707

View more
  31 in total

1.  Mapping a noncovalent protein-peptide interface by top-down FTICR mass spectrometry using electron capture dissociation.

Authors:  David J Clarke; Euan Murray; Ted Hupp; C Logan Mackay; Pat R R Langridge-Smith
Journal:  J Am Soc Mass Spectrom       Date:  2011-05-11       Impact factor: 3.109

2.  Foxp1/4 control epithelial cell fate during lung development and regeneration through regulation of anterior gradient 2.

Authors:  Shanru Li; Yi Wang; Yuzhen Zhang; Min Min Lu; Francesco J DeMayo; Joseph D Dekker; Philip W Tucker; Edward E Morrisey
Journal:  Development       Date:  2012-06-06       Impact factor: 6.868

3.  Tumor-secreted anterior gradient-2 binds to VEGF and FGF2 and enhances their activities by promoting their homodimerization.

Authors:  H Guo; Q Zhu; X Yu; S B Merugu; H B Mangukiya; N Smith; Z Li; B Zhang; H Negi; R Rong; K Cheng; Z Wu; D Li
Journal:  Oncogene       Date:  2017-05-08       Impact factor: 9.867

4.  AGR2 promotes the proliferation, migration and regulates epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.

Authors:  Si-Rui Ma; Liang Mao; Wei-Wei Deng; Yi-Cun Li; Lin-Lin Bu; Guang-Tao Yu; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

5.  CD147 and AGR2 expression promote cellular proliferation and metastasis of head and neck squamous cell carcinoma.

Authors:  Larissa Sweeny; Zhiyong Liu; Benjamin D Bush; Yolanda Hartman; Tong Zhou; Eben L Rosenthal
Journal:  Exp Cell Res       Date:  2012-05-30       Impact factor: 3.905

6.  Anterior gradient protein 2 (AGR2) is an independent prognostic factor in ovarian high-grade serous carcinoma.

Authors:  S Darb-Esfahani; F Fritzsche; G Kristiansen; W Weichert; J Sehouli; I Braicu; M Dietel; C Denkert
Journal:  Virchows Arch       Date:  2012-07-03       Impact factor: 4.064

7.  The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients.

Authors:  Dong L Barraclough; Angela Platt-Higgins; Suzete de Silva Rudland; Roger Barraclough; John Winstanley; Christopher R West; Philip S Rudland
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

8.  Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival.

Authors:  Vijaya Ramachandran; Thiruvengadam Arumugam; Huamin Wang; Craig D Logsdon
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

9.  Anterior gradient-2 is overexpressed by fibrolamellar carcinomas.

Authors:  Perumal Vivekanandan; Shien T L Micchelli; Michael Torbenson
Journal:  Hum Pathol       Date:  2008-10-29       Impact factor: 3.466

Review 10.  The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker.

Authors:  Michael L Salmans; Fang Zhao; Bogi Andersen
Journal:  Breast Cancer Res       Date:  2013-04-24       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.